Concepedia

Jas Gill

JG

5

Publications

585

Citations

5

H-Index

1999

Active since

Affiliations

Chelsea and Westminster Hospital(Current)

Jas Gill is an author at Chelsea and Westminster Hospital specializing in medicine, pathology, and allergy.

Top concepts

Publications per year

1999–2003

5

Publications

5

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma

Simon Portsmouth, Justin Stebbing, Jas Gill et al. · AIDS · 2003 · 180 citations

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi‚s sarcoma

Mark Bower, Paul Fox, Kate Fife et al. · AIDS · 1999 · 169 citations

Loss of CD4<sup>+</sup>T Cell Proliferative Ability but Not Loss of Human Immunodeficiency Virus Type 1 Specificity Equates with Progression to Disease

Jamie Wilson, Nesrina Imami, Amanda Watkins et al. · The Journal of Infectious Diseases · 2000 · 121 citations · Full text

Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy

John Wilkinson, Alethea Cope, Jas Gill et al. · Journal of Virology · 2002 · 103 citations · Full text

, , +16

HAART PROLONGS TIME TO TREATMENT FAILURE (TTF) IN KAPOSI'S SARCOMA (KS).

Mark Bower, P. H. Fox, Kate Fife et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 1999 · 12 citations

, , +11

Rows per page

1–5 of 5